Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 4, Juillet 2018
Médecine interne et transversalité
Page(s) 291 - 299
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0034
Publié en ligne 6 juin 2018
  • Goldstein AR, White RH, Akuse R, Chantler C, (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339: 280–282 [CrossRef] [PubMed] [Google Scholar]
  • Ronkainen J, Nuutinen M, Koskimies O, (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360: 666–670 [CrossRef] [PubMed] [Google Scholar]
  • Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D, (2002) Henoch-Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13: 1271–1278 [CrossRef] [Google Scholar]
  • Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR, (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360: 1197–1202 [CrossRef] [PubMed] [Google Scholar]
  • Watts RA, Lane S, Scott DG, (2005) What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19: 191–207 [CrossRef] [Google Scholar]
  • Penny K, Fleming M, Kazmierczak D, Thomas A, (2010) An epidemiological study of Henoch-Schönlein purpura. Paediatr Nurs 22: 30–35 [CrossRef] [Google Scholar]
  • Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA, (1997) Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40: 859–864 [CrossRef] [PubMed] [Google Scholar]
  • Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H, (2004) Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis. Pediatr Nephrol 19: 920–923 [CrossRef] [PubMed] [Google Scholar]
  • Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA, (2002) Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32: 149–156 [CrossRef] [PubMed] [Google Scholar]
  • Pillebout E, Jamin A, Ayari H, Housset P, Pierre M, Sauvaget V, Viglietti D, Deschenes G, Monteiro RC, Berthelot L, (2017) Biomarkers of IgA vasculitis nephritis in children. PLoS One 12: e0188718 [CrossRef] [PubMed] [Google Scholar]
  • Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69: 798–806 [CrossRef] [PubMed] [Google Scholar]
  • Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, Cacoub P, Jourde-Chiche N, Urbanski G, Augusto JF, Moulis G, Raffray L, Deroux A, Hummel A, Lioger B, Catroux M, Faguer S, Goutte J, Martis N, Maurier F, Riviere E, Sanges S, Baldolli A, Costedoat-Chalumeau N, Roriz M, Puechal X, Andre M, Lavigne C, Bienvenu B, Mekinian A, Zagdoun E, Girard C, Berezne A, Guillevin L, Thervet E, Pillebout E, (2017) Characteristics and management of IgA vasculitis (Henoch-Schönlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol 69: 1862–1870 [CrossRef] [PubMed] [Google Scholar]
  • Zhang Y, Huang X, (2008) Gastrointestinal involvement in Henoch-Schönlein purpura. Scand J Gastroenterol 43: 1038–1043 [CrossRef] [PubMed] [Google Scholar]
  • Kaswala D, Chodos A, Ahlawat S, (2016) Henoch-Schönlein Purpura With Gastrointestinal Involvement in an Adult Patient. Gastroenterol Hepatol (N Y) 12: 321–323 [PubMed] [Google Scholar]
  • Yamazaki T, Akimoto T, Iwazu Y, Sugase T, Takeshima E, Numata A, Komada T, Yoshizawa H, Otani N, Morishita Y, Saito O, Takemoto F, Muto S, Kusano E, Nagata D, (2015) Henoch-Schönlein purpura complicated with severe gastrointestinal bleeding. CEN Case Rep 4: 106–111 [CrossRef] [PubMed] [Google Scholar]
  • Garzoni L, Vanoni F, Rizzi M, Simonetti GD, Goeggel Simonetti B, Ramelli GP, Bianchetti MG, (2009) Nervous system dysfunction in Henoch-Schönlein syndrome: systematic review of the literature. Rheumatology (Oxford) 48: 1524–1529 [CrossRef] [PubMed] [Google Scholar]
  • Lava SA, Peeters GG, Bianchetti MG, Goeggel Simonetti B, Simonetti GD, Milani GP, (2017) Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura. Rheumatol Int 37: 461–463 [CrossRef] [PubMed] [Google Scholar]
  • Rajagopala S, Parameswaran S, Ajmera JS, Ganesh RN, Katrevula A, (2017) Diffuse alveolar hemorrhage in IgA nephropathy: case series and systematic review of the literature. Int J Rheum Dis 20: 109–121 [CrossRef] [PubMed] [Google Scholar]
  • Rajagopala S, Shobha V, Devaraj U, D’Souza G, Garg I, (2013) Pulmonary hemorrhage in Henoch-Schönlein purpura: case report and systematic review of the english literature. Semin Arthritis Rheum 42: 391–400 [CrossRef] [PubMed] [Google Scholar]
  • Chen SY, Chang KC, Yu MC, Asueh S, Ou LS, (2011) Pulmonary hemorrhage associated with Henoch-Schönlein purpura in pediatric patients: case report and review of the literature. Semin Arthritis Rheum 41: 305–312 (doi: 10.1016/j.semarthrit.2011.03.007) [CrossRef] [PubMed] [Google Scholar]
  • Rostoker G, (2001) Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 15: 99–138 [CrossRef] [PubMed] [Google Scholar]
  • Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA, (2001) Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 80: 279–290 [CrossRef] [PubMed] [Google Scholar]
  • Saulsbury FT, (1999) Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78: 395–409 [CrossRef] [PubMed] [Google Scholar]
  • Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M, (2005) Henoch Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35: 143–153 [CrossRef] [PubMed] [Google Scholar]
  • Rieu P, Noel LH, (1999) Henoch-Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 150: 151–159 [PubMed] [Google Scholar]
  • Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E, Monteiro RC, Pillebout E, (2018) Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant (2017 Nov 3. doi: 10.1093/ndt/gfx300. [Epub ahead of print]) [Google Scholar]
  • Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, Kibe Y, Hattori N, Takeuchi J, (1978) Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: Clinicopathological and immunohistological characteristics. Q J Med 47: 495–516 [PubMed] [Google Scholar]
  • Davin JC, Ten Berge IJ, Weening JJ, (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59: 823–834 [CrossRef] [PubMed] [Google Scholar]
  • Droz D, Lantz B (1995) Biopsie rénale. Inserm, Paris, 151–153 [Google Scholar]
  • Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC, Wang H, (2013) Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 62: 891–899 [CrossRef] [PubMed] [Google Scholar]
  • Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC, (2011) Validation of the Oxford classification of IgA nephropathy. Kidney Int 80: 310–317 [CrossRef] [PubMed] [Google Scholar]
  • Podjasek JO, Wetter DA, Pittelkow MR, Wada DA, (2012) Henoch-Schönlein purpura associated with solid-organ malignancies: three case reports and a literature review. Acta Derm Venereol 92: 388–392 [CrossRef] [PubMed] [Google Scholar]
  • Nadrous HF, Yu AC, Specks U, Ryu JH, (2004) Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc 79: 1151–1157 [PubMed] [Google Scholar]
  • Narchi H, (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90: 916–920 [CrossRef] [PubMed] [Google Scholar]
  • Hahn D, Hodson EM, Willis NS, Craig JC, (2015) Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP) (Review). Cochrane Database Syst Rev 8:CD005128 (doi: 10.1002/14651858.CD005128.pub3) [Google Scholar]
  • Kawasaki Y, Suyama K, Hashimoto K, Hosoya M, (2011) Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis. Clin Rheumatol 30: 529–535 [CrossRef] [PubMed] [Google Scholar]
  • Niaudet P, Habib R, (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12: 238–243 [CrossRef] [PubMed] [Google Scholar]
  • Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E, (2010) Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura. Kidney Int 78: 495–502 [CrossRef] [PubMed] [Google Scholar]
  • Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A, (2017) Brief report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein). Arthritis Rheumatol 70: 109–114 [CrossRef] [PubMed] [Google Scholar]
  • group Kw, (2012) Chapter 11: Henoch-Schönlein purpura. Kidney Int Suppl 2: 218–220 [CrossRef] [Google Scholar]
  • Cherqaoui B, Chausset A, Stephan JL, Merlin E, (2016) Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a French retrospective study. Arch Pediatr 23: 584–590 [CrossRef] [PubMed] [Google Scholar]
  • Donghi D, Schanz U, Sahrbacher U, Recher M, Trueb RM, Mullhaupt B, French LE, Hafner J, (2009) Life-threatening or organ-impairing Henoch-Schönlein purpura: plasmapheresis may save lives and limit organ damage. Dermatology 219: 167–170 [CrossRef] [PubMed] [Google Scholar]
  • Chaudhary K, Shin JY, Saab G, Luger AM, (2008) Successful treatment of Henoch-Schönlein purpura nephritis with plasma exchange in an adult male. NDT Plus 1: 303–306 [Google Scholar]
  • Shenoy M, Bradbury MG, Lewis MA, Webb NJ, (2007) Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22: 1717–1722 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.